@FiercePharma: GSK readies 500 reps for Horizant launch. Story | Follow @FiercePharma
> Merck has lost a U.K. court bid to reinstate its European patent for the glaucoma treatment Cosopt after a successful challenge by Teva Pharmaceutical Industries. Report
> Cephalon won a court order that prevents generic-drug makers from selling low-cost versions of its muscle relaxant Amrix until a judge rules on a patent dispute over the drug. News
> Sanofi-Aventis completed its takeover of U.S. biotech Genzyme, whose shares ceased trading on the Nasdaq as of the market close on Friday. Article
> Danish biopharma Bavarian Nordic said it had extended a smallpox contract with the U.S. government to $94 million from $40 million. Story
> Valeant Pharmaceuticals said it might be willing to increase its takeover offer for Cephalon if the U.S. drugmaker agreed to open its books to due diligence. Report
> Impax Laboratories said it will sell two softgel capsule drugs made by Banner Pharmacaps as part of a new partnership. Item
> Swiss drugs industry supplier Lonza is not interested in buying rivals Siegfried and Bachem, Lonza's chief executive told a Swiss newspaper. Story
> The United Arab Emirates' national fund for the purchase of medicines has doubled, from 150 million dirhams in 2010 to 300 million dirhams ($81 million) for this year. News
> GW Pharmaceuticals has signed up Novartis to sell its cannabis-based drug Sativex in a range of markets--including Australia, the Middle East and Africa--marking a key endorsement for the treatment from the major Swiss pharmaceutical company. Report
> California's treasurer became the second state official to ask leading makers of AIDS medications to extend lower prices and rebates for drugs to help the state's budget crisis. News
A British man was jailed for eight years for his role in supplying more than 2 million doses of fake medicines in the most serious known case of counterfeit drugs getting into the European supply chain. Story
Biotech News
@FierceBiotech: Beleaguered Ambrilia faces bankruptcy. Report | Follow @FierceBiotech
@JohnCFierce: CF Foundation clearly very impressed with Vertex. Doubles down on R&D pact, adds $75M. Story | Follow @JohnCFierce
> Biogen flags Ph3 success for crucial MS drug. Report
> Medivation's Dimebon flunks Ph3 for Huntington's disease. Article
> Third Rock launches cancer drug developer with $40M bankroll. Item
Biotech IT News
> LifeMap born to create stem cell database. Item
> DZS Software enters partnership with Medidata. Story
> PatientsLikeMe reveals strategy change. Article
> Informatics enables new "point-of-care" trials. Report
> Complete Genomics stocks up public genome repository. Item
Medical Device News
> Depuy pays $7.9 million to end UK bribe case. Story
> Medtronic combines U.S. cardiac, vascular sales groups. Report
> PixelOptics snags $45M investment. Item
> Biotronik responds to NYT report. Article
> Study: Patients in stroke device trials don't resemble typical patients. Report
> Endo to buy AMS for $2.9M. News
> St. Jude signs contract with GPO Novation. Item
And Finally... As prescription drug abuse ravages communities across the country, doctors are confronting an emerging challenge: newborns dependent on painkillers. Report